Cited by 71Enhanced Recovery After SurgeryDiabetes Treatment and ManagementGastrointestinal Bleeding Diagnosis and Treatment

Association of glucagon-like peptide receptor 1 agonist therapy with the presence of gastric contents in fasting patients undergoing endoscopy under anesthesia care: a historical cohort study

Open access
Wu, Fei, Smith, Matthew R., Mueller, Ariel L., Klapman, Seth A., Everett, Lucinda L., Houle, Timothy, Kuo, Braden, Hobai, Ion A.·2024·Canadian Journal of Anesthesia/Journal canadien d'anesthésie

Abstract

Purpose We aimed to estimate the association of glucagon-like peptide 1 (GLP-1) receptor agonist therapy with the incidence of endoscopically visible gastric contents after preprocedural fasting. Methods We reviewed the records of esophagogastroduodenoscopy (EGD) performed at our institution between 2019 and 2023 and determined the presence of residual gastric contents from the procedure notes and saved images. We compared patients taking GLP-1 agonists at the time of the procedure (GLP group, 90 procedures) with patients who started GLP-1 agonist therapy within 1,000 days after undergoing EGD (control, 102 procedures). We excluded emergent procedures without fasting, combined EGD/colonoscopy procedures, and patients with known gastroparesis or previous gastric surgery. We estimated the association between GLP-1 agonist therapy and residual gastric contents with a confounder-adjusted generalized linear mixed effect model. Results Compared with controls, the GLP cohort had a higher age, American Society of Anesthesiologists' Physical Status, and incidence of nausea and diabetes mellitus. Body mass index and fasting duration were comparable between groups. Visible gastric content was documented in 17 procedures in the GLP group (19%) and in five procedures in the control group (5%), with an associated confounder adjusted odds ratio of 5.8 (95% confidence interval, 1.7 to 19.3; P = 0.004). There were five instances of emergent endotracheal intubation in the GLP group vs one case in control and one case of pulmonary aspiration vs none in control. Conclusions In fasting patients, GLP-1 agonist therapy was associated with an increased incidence of residual gastric contents, potentially posing an additional risk of periprocedural pulmonary aspiration.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s12630-024-02719-z

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 12

  1. Wilson PR, Bridges KH, Wilson SH. Particulate gastric contents in patients prescribed glucagon-like peptide 1 receptor agonists after appropriate perioperative fasting: a report of 2 cases. A A Pract 2023; 17: e01712. https://doi.org/10.1213/xaa. 0000000000001712 · DOI
  2. Sherwin M, Hamburger J, Katz D, DeMaria S Jr. Influence of semaglutide use on the presence of residual gastric solids on gastric ultrasound: a prospective observational study in volunteers without obesity recently started on semaglutide. Can J Anesth 2023; 70: 1300-6. https://doi.org/10.1007/s12630-023- 02549-5 · DOI · Paper page
  3. Silveira SQ, da Silva LM, de Campos Vieira Abib A, et al. Relationship between perioperative semaglutide use and residual gastric content: a retrospective analysis of patients undergoing elective upper endoscopy. J Clin Anesth 2023; 87: 111091. https://doi.org/10.1016/j.jclinane.2023.111091 · DOI · Paper page
  4. Hulst AH, Polderman JA, Siegelaar SE, et al. Preoperative considerations of new long-acting glucagon-like peptide-1 receptor agonists in diabetes mellitus. Br J Anaesth 2021; 126: 567-71. https://doi.org/10.1016/j.bja.2020.10.023 · DOI
  5. Hjerpsted JB, Flint A, Brooks A, Axelsen MB, Kvist T, Blundell J. Semaglutide improves postprandial glucose and lipid metabolism, and delays first-hour gastric emptying in subjects with obesity. Diabetes Obes Metab 2018; 20: 610-9. https://doi. org/10.1111/dom.13120 · DOI · Paper page
  6. Hulst AH, Visscher MJ, Godfried MB, et al. Liraglutide for perioperative management of hyperglycaemia in cardiac surgery patients: a multicentre randomized superiority trial. Diabetes Obes Metab 2020; 22: 557-65. https://doi.org/10.1111/dom. 13927 · DOI · Paper page
  7. Hulst AH, Plummer MP, Hollmann MW, et al. Systematic review of incretin therapy during peri-operative and intensive care. Crit Care 2018; 22: 299. https://doi.org/10.1186/s13054-018-2197-4 · DOI
  8. Watanabe H, Adachi W, Koide N, Yazawa I. Food residue at endoscopy in patients who have previously undergone distal gastrectomy: risk factors and patient preparation. Endoscopy 2003; 35: 397-401.https://doi.org/10.1055/s-2003-38776 · DOI
  9. Bi D, Choi C, League J, Camilleri M, Prichard DO. Food residue during esophagogastroduodenoscopy is commonly encountered and is not pathognomonic of delayed gastric emptying. Dig Dis Sci 2021; 66: 3951-9. https://doi.org/10.1007/s10620-020-06718-0 · DOI
  10. Deane AM, Chapman MJ, Fraser RJ, et al. Effects of exogenous glucagon-like peptide-1 on gastric emptying and glucose absorption in the critically ill: relationship to glycemia. Crit Care Med 2010; 38: 1261-9. https://doi.org/10.1097/ccm. 0b013e3181d9d87a · DOI · Paper page
  11. Jones PM, Hobai IA, Murphy PM. Anesthesia and glucagon-like peptide-1 receptor agonists: proceed with caution! Can J Anesth 2023; 70: 1281-6. https://doi.org/10.1007/s12630-023-02550-y · DOI
  12. El-Boghdadly K, Wojcikiewicz T, Perlas A. Perioperative point- of-care gastric ultrasound. BJA Educ 2019; 19: 219-26. https:// doi.org/10.1016/j.bjae.2019.03.003 · DOI

Cited by

Sorted by citations

Authors
Wu, F., Smith, M. R., Mueller, A. L., Klapman, S. A., Everett, L. L., Houle, T., Kuo, B., & Hobai, I. A.
Affiliations
  • Massachusetts General Hospital (US)
  • Harvard University (US)
Corresponding author
Hobai, Ion A.
Venue
Canadian Journal of Anesthesia/Journal canadien d'anesthésie
Published
2024-03-14
Volume
71
Issue
7
Pages
958-966
ISSN
  • 0832-610X (ISSN-L)
  • 1496-8975
OpenAlex
W4392796059
Cited by
71
References
6
Citations by year
2026: 10 · 2025: 38 · 2024: 23
FWCI
29.99
Type
journal article
Language
en
Open access
Locations
  • Canadian Journal of Anesthesia/Journal canadien d anesthésie (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Enhanced Recovery After Surgery
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal Bleeding Diagnosis and Treatment
Keywords
GLP-1 receptor agonists, residual gastric content, preprocedural fasting, upper gastrointestinal endoscopy, pulmonary aspiration, endotracheal intubation, diabetes mellitus, gastroparesis
MeSH terms
Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor Agonists, Adult, Aged, Anesthesia, Fasting, Female, Gastrointestinal Contents, Humans, Male, Middle Aged, Retrospective Studies, Cohort Studies, Endoscopy, Digestive System

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review